PLEKHA5 and melanoma: Although our analysis of public single-cell sequencing datasets revealed upregulation of PLEKHA5 in melanoma patients with brain metastasis, the elevated expression of the PLEKHA5-L isoform requires further validation using advanced splicing analysis technologies capable of resolving isoform-specific contributions in heterogeneous tumor contexts (17).